Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Danaher

Danaher
1969 FOUNDED
PUBLIC STATUS
70K-75K EMPLOYEES
DHR STOCK SYMBOL
74 INVESTMENTS
$135.23 SHARE PRICE (As of Friday Closing)
Description

In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in four segments: life sciences (33% of 2018 sales), diagnostics (31%), environmental and applied solutions (22%), and dental (14%). In 2019, Danaher plans to separate its dental business from the organization through an initial public offering, and Danaher also plans to acquire GE's Biopharma business, which will add to its life sciences segment.

Website
Formerly Known As
Diversified Mortgage Investors, DMG
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Holding Companies
Other Industries
Environmental Services (B2B)
Medical Supplies
Stock Exchange
NYS
Primary Office
  • 2200 Pennsylvania Avenue, North West
  • Suite 800 West
  • Washington, DC 20037
  • United States

+1 (202) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Danaher’s full profile, request a free trial.

Danaher Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$94.59 - $147.33 $97.1B $134.50 $3.42 2.13M 718M

Danaher Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 110,085,502 82,130,487 74,831,680 61,255,693
Revenue 20,437,300 19,893,000 18,329,700 16,882,400
EBITDA 4,750,600 4,748,700 4,332,300 3,923,600
Net Income 2,479,900 2,650,900 2,492,100 2,553,700
Total Assets 61,531,100 47,832,500 46,648,600 45,295,300
Total Debt 17,604,800 9,740,300 10,522,100 12,269,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Danaher Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Danaher‘s full profile, request access.

Request full access to PitchBook

Danaher Investments & Acquisitions (74)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00 (000000000 0000 25-Feb-2019 000000000000000000 000.00 Pharmaceuticals
0000000000 000 000 01-Apr-2018 000000000000000000 000 Specialty Chemicals 000000 00000 00.
00 00000000 000000 30-Oct-2017 000000000000000000 Other Information Technology 000000 00000
00000000 000000 00 28-Feb-2017 000000000000000000 00000 Industrial Supplies and Parts 000000 0000000000
Cepheid 04-Nov-2016 Merger/Acquisition 000 Diagnostic Equipment 000000 00000 00.
To view this company’s complete investment and acquisition history, request access »

Danaher Exits (10)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000 00000 06-Jul-2010 00000 0000000 Completed
  • 2 buyers
000000000 21-Nov-2007 000000000000000000 00.000 Completed
  • 0000000
00000000 000000000 21-Sep-2004 00000 00000 00 000.00 Completed
  • 3 buyers
00000000 00000000 01-Mar-2004 000000000000000000 Completed
  • 0000000
Accu-Sort Systems 21-Nov-2003 Merger/Acquisition 0000 Completed
To view this company’s complete exits history, request access »

Danaher Subsidiaries (32)

Company Name Industry Location Founded
Cepheid Diagnostic Equipment Sunnyvale, CA 1996
000000 Other Healthcare Oxnard, CA 0000
0000000 00000000 0 Diagnostic Equipment Edingen-Neckarhausen, Germany 0000
0000000 00000000 0 Diagnostic Equipment Hatfield, PA 0000
00000000 000000 00 Industrial Supplies and Parts Hod Hasharon, Israel 0000
To view this company’s complete subsidiary history, request access »

Danaher Executive Team (68)

Name Title Board
Seat
Contact
Info
Thomas Joyce Jr. Chief Executive Officer & Board Member
Matthew McGrew Chief Financial Officer & Executive Vice President
Michael Egholm Ph.D Chief Technology Officer, Danaher Life Sciences
Robert Lutz Chief Accounting Officer & Senior Vice President
Andrew Moline Director, Global Benefits

37 Former Executives

You’re viewing 5 of 68 executives. Get the full list »

Danaher Board Members (8)

Name Representing Role Since Contact
Info
0000 00000 00 Self Board Member 000 0000
000000 0000000 00. Self Board Member 000 0000
00000 00000000 00 Self Board Member 000 0000
00000000 00000 Self Founder & Board Member 000 0000
000000 000000000 Danaher Chairman, European Board, Corporate Officer, Vice President & Managing Director 000 0000
You’re viewing 5 of 8 board members. Get the full list »